Psychosis in Parkinson s and Alzheimer s Disease Market Size in the 7MM is anticipated to increase by 2034, estimates DelveInsight medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
On Tuesday, Johnson & Johnson (NYSE:JNJ) reported fourth-quarter 2023 adjusted earnings of $2.29 per share, up 11.7% year-over-year, beating the consensus of $2.28. Sales increased 7.3% Y/Y to $21.4 billion, beating the consensus of $20.99 billion, with operational growth of 7.2% and adjusted operational growth of 5.7%. Operational growth, excluding the COVID-19 Vaccine, was 10.9%. Pharmaceutical segment sales increased by 4.2% to $13.72 billion. Darzalex (cancer drug) and Stelara (Crohn’s disea
Researchers Identify Cause of Heart Failure in Individuals With Obesity theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.
New York, USA, Aug. 02, 2023 (GLOBE NEWSWIRE) Alzheimer's Disease Market Predicted to Surge at a CAGR of 20% During the Study Period (2019–2032), Assesses DelveInsight The Alzheimer's disease market size is
/PRNewswire/ DelveInsight s Parkinson s Disease Market Insights report includes a comprehensive understanding of current treatment practices, Parkinson s.